Cargando…
Antipsychotic use and psychiatric disorders in COVID-19
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906667/ https://www.ncbi.nlm.nih.gov/pubmed/33665642 http://dx.doi.org/10.1016/S2666-7568(20)30063-5 |
_version_ | 1783655338792189952 |
---|---|
author | Ferraris, Augusto Angriman, Federico Szmulewicz, Alejandro G |
author_facet | Ferraris, Augusto Angriman, Federico Szmulewicz, Alejandro G |
author_sort | Ferraris, Augusto |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7906667 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Author(s). Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-79066672021-02-26 Antipsychotic use and psychiatric disorders in COVID-19 Ferraris, Augusto Angriman, Federico Szmulewicz, Alejandro G Lancet Healthy Longev Correspondence The Author(s). Published by Elsevier Ltd. 2021-02 2021-02-03 /pmc/articles/PMC7906667/ /pubmed/33665642 http://dx.doi.org/10.1016/S2666-7568(20)30063-5 Text en © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Ferraris, Augusto Angriman, Federico Szmulewicz, Alejandro G Antipsychotic use and psychiatric disorders in COVID-19 |
title | Antipsychotic use and psychiatric disorders in COVID-19 |
title_full | Antipsychotic use and psychiatric disorders in COVID-19 |
title_fullStr | Antipsychotic use and psychiatric disorders in COVID-19 |
title_full_unstemmed | Antipsychotic use and psychiatric disorders in COVID-19 |
title_short | Antipsychotic use and psychiatric disorders in COVID-19 |
title_sort | antipsychotic use and psychiatric disorders in covid-19 |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906667/ https://www.ncbi.nlm.nih.gov/pubmed/33665642 http://dx.doi.org/10.1016/S2666-7568(20)30063-5 |
work_keys_str_mv | AT ferrarisaugusto antipsychoticuseandpsychiatricdisordersincovid19 AT angrimanfederico antipsychoticuseandpsychiatricdisordersincovid19 AT szmulewiczalejandrog antipsychoticuseandpsychiatricdisordersincovid19 |